Skip to content
Biodatica
Start free

Investigator

Roberto Zoncu

UNIVERSITY OF CALIFORNIA BERKELEY · funded by NINDS, NIGMS, NCI

Companies
1

Resolved onto their grants.

Grants
6

Federal awards on file.

Non-dilutive funding
$3.5M

Summed across those awards.

First award
Mar 21, 2022

Latest Apr 15, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Deciphering and disabling lysosome-dependent mechanisms of neurodegeneration

    $576k

    Apr 15, 2024NINDSUNIVERSITY OF CALIFORNIA BERKELEYNIH RePORTER · 11064059 (opens the source filing in a new tab)

  2. R01

    Deciphering and disabling lysosome-dependent mechanisms of neurodegeneration

    $571k

    Apr 15, 2024NINDSUNIVERSITY OF CALIFORNIA BERKELEYNIH RePORTER · 11260241 (opens the source filing in a new tab)

  3. R35

    Molecular Mechanisms of Organelle-based Metabolic Signaling

    $614k

    May 1, 2023NIGMSUNIVERSITY OF CALIFORNIA BERKELEYNIH RePORTER · 11074674 (opens the source filing in a new tab)

  4. R35

    Molecular Mechanisms of Organelle-based Metabolic Signaling

    $614k

    May 1, 2023NIGMSUNIVERSITY OF CALIFORNIA BERKELEYNIH RePORTER · 11321294 (opens the source filing in a new tab)

  5. R01

    Dissecting and targeting lysosomal signaling in kidney tumorigenesis

    $544k

    Mar 21, 2022NCIUNIVERSITY OF CALIFORNIA BERKELEYNIH RePORTER · 11041147 (opens the source filing in a new tab)

  6. R01

    Dissecting and targeting lysosomal signaling in kidney tumorigenesis

    $544k

    Mar 21, 2022NCIUNIVERSITY OF CALIFORNIA BERKELEYNIH RePORTER · 11294178 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources